VivoSim Labs, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $131.0K | $144.0K | $109.0K | $370.0K | $1.5M | $0 | $2.2M | $3.1M |
| Cost of Revenue | $0 | $5.0K | — | — | — | $0 | $300.0K | $500.0K |
| Gross Profit | $131.0K | $139.0K | — | — | — | $0 | $1.9M | $2.6M |
| Gross Margin | 100.0% | 96.5% | — | — | — | — | 86.3% | 83.8% |
| Operating Expenses | ||||||||
| Research & Development | $4.2M | $5.0M | $5.5M | $8.9M | $3.3M | $1.1M | $5.3M | $14.8M |
| SG&A Expense | $7.4M | $7.7M | $9.7M | $9.2M | $9.7M | $15.7M | $18.1M | $15.1M |
| Operating Income | $-11.5M | $-12.6M | $-15.1M | $-17.7M | $-11.5M | $-16.8M | $-21.5M | $-27.3M |
| Operating Margin | -8,768.7% | -8,761.1% | -13,840.4% | -4,792.2% | -765.3% | — | -977.9% | -882.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-13.8M | $-2.5M | — | — | — | — | — | — |
| Income Tax Expense | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K |
| Net Income | $-13.8M | $-2.5M | $-14.7M | $-17.3M | $-11.4M | $-16.8M | $-18.7M | $-26.6M |
| Net Margin | -10,567.2% | -1,727.8% | -13,459.6% | -4,664.6% | -763.2% | — | -852.0% | -861.7% |
| EPS (Basic) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | $-2.44 | $-2.80 | $-0.23 |
| EPS (Diluted) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | $-2.44 | $-2.80 | $-0.23 |
| Shares Outstanding (Basic) | 2.6M | 1.5M | 762.1K | 8.7M | 8.7M | 8.7M | 130.6M | 130.2M |
| Shares Outstanding (Diluted) | 2.6M | 1.5M | 762.1K | 8.7M | 8.7M | 8.7M | 130.6M | 130.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |